<DOC>
	<DOC>NCT00120939</DOC>
	<brief_summary>The primary purpose of this study is to evaluate the safety, side effects, and dosage for Motexafin Gadolinium given with the chemotherapy drug docetaxel to patients with advanced cancers. Secondly, tumor response to the combined treatment, drug levels in the body, and drug interactions will be evaluated.</brief_summary>
	<brief_title>Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Motexafin gadolinium</mesh_term>
	<criteria>At least 18 years old Metastatic, or unresectable solid tumors from breast, head, and neck, gastrointestinal, genitourinary, lung, or ovarian cancer or recurrent glioblastoma multiforme ECOG performance status score either 0, 1, or 2 Willing and able to provide written informed consent Greater than two prior cytotoxic regimens Laboratory values showing adequate function of bone marrow, liver, and kidneys Uncontrolled hypertension Known sensitivity to or intolerable adverse effects from taxanes (eg. paclitaxel, docetaxel) or polysorbate 80</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Lung Cancer</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Prostate Cancer</keyword>
	<keyword>Ovarian Cancer</keyword>
	<keyword>Head and Neck Cancer</keyword>
	<keyword>Gastrointestinal Cancer</keyword>
	<keyword>Metastatic Cancer</keyword>
	<keyword>Advanced Cancer</keyword>
	<keyword>Genitourinary Cancer</keyword>
	<keyword>Glioblastoma Multiforme</keyword>
	<keyword>Recurrent Cancer</keyword>
	<keyword>Colon Cancer</keyword>
	<keyword>Gastric Cancer</keyword>
	<keyword>Stomach Cancer</keyword>
	<keyword>Pancreatic Cancer</keyword>
	<keyword>Esophageal Cancer</keyword>
	<keyword>Throat Cancer</keyword>
	<keyword>Bladder Cancer</keyword>
	<keyword>Kidney Cancer</keyword>
	<keyword>Renal Cancer</keyword>
	<keyword>Cervical Cancer</keyword>
	<keyword>Endometrial Cancer</keyword>
	<keyword>Colorectal Cancer</keyword>
</DOC>